Finally, activation of the Bruton tyrosine kinase (BTK) in B-cells has been shown to foster reprogramming of tumor infiltrating macrophages towards a M2 phenotype thus impairing CD8+ T-cell anti-tumor responses and supporting PDAC growth (62, 65, 140) (Figure 2). Here, BTK is linked to neoplasm.